Predictors of orphan drug approval in the European Union

OBJECTIVE: To encourage the development of drugs for rare diseases, orphan drug legislation has been introduced in the USA (1983) and in the EU (2000). Recent literature discusses factors that may influence the development of new orphan medicinal products in the EU. This study aims to identify predi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Heemstra, Harald E., de Vrueh, Remco L., van Weely, Sonja, Büller, Hans A., Leufkens, Hubert G. M.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer-Verlag 2008
Assuntos:
Pharmacoepidemiology and Prescription
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2668549/
https://ncbi.nlm.nih.gov/pubmed/18210097
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00228-007-0454-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados